期刊文献+

不同全段甲状旁腺激素水平对维持性血液透析患者临床指标影响及相关因素分析 被引量:8

The influence of serum intact parathyroid levels on clinical variables and its related factors in patients undergoing maintenance hemodialysis
下载PDF
导出
摘要 目的探讨不同全段甲状旁腺激素(intact parathyroid hormone,iPTH)水平对维持性血液透析(maintenance hemodialysis,MHD)患者临床指标的影响,并进行相关因素分析。方法选取HD患者共93例,测定iPTH及血生化指标,根据血iPTH水平分为A组iPTH<150pg/ml,B组iPTH150~300pg/ml,C组iPTH>300pg/ml,比较3组年龄、糖尿病患病率、透析龄、体质量、体质量指数及血生化等临床指标,采用多元线性回归分析血iPTH与年龄、性别、糖尿病、透析龄、血校正钙、血磷、血碱性磷酸酶的相关性。结果 A组相比,B、C组的年龄、肌酐和血磷水平均显著升高(P<0.05);A组的糖尿病患病率最高,B组和C组依次减少,差异有统计学意义(÷2=11.393,P=0.03);3组的iPTH、透析龄、血校正钙及ALP水平相比,差异有统计学意义(F=81.619,28.589,6.129,7.384;P=0.000,0.000,0.042,0.025),C组最高,其中B组与A组的iPTH及透析龄依次降低;多元线性回归分析表明,iPTH的平方根即Sqrt(iPTH)与透析龄(回归系数0.102)及血磷(回归系数3.077)成正相关,与糖尿病(回归系数-1.294)成负相关。结论 iPTH水平可影响MHD患者的预后;iPTH与透析龄、血磷呈正相关,与糖尿病呈负相关。 Objective To investigate and analyze the influence of serum intact parathyroid hormone (iPTH) levels on biochemical variables and its related factors in patients undergoing maintenance hemodialysis (MHD). Methods Ninety-three CKD patients on MHD were divided into 3 groups based on serum iPTH level (group A, iPTH 〈 150 pg/m; group B, iPTH 150-300 pg/ml; group C, iPTH 〉 300 pg/ ml). Age, prevalence of diabetes, duration on dialysis, body weight, BMI, and serum biochemical variables were compared among the 3 groups. Multiple linear regression was used to disclose the relationship between serum iPTH and the variables of age, gender, diabetes mellitus, duration on dialysis, serum calcium (Ca), phosphorus (P), and alkaline phosphates (ALP). Results Age, serum creatinine and P were significantly higher in group B and C than in group A (P 〈 0.05). The diabetes morbidity was higher in group A, lower in group B, and lowest in group C (χ^2=1 1.393, P=-0.03). Serum iPTH, Ca, ALP and duration on dialysis were compared among the three groups, and the remarkable differences were found (F=81.619, 28.589, 6.129, and 7.384, respectively; P=0.000, 0.000, 0.042, and 0.025, respectively). Serum iPTH, Ca, ALP and duration on dialysis were higher in group C, lower in group B, and lowest in group A. Multiple linear regression demonstrated that the square root of iPTH value was positively correlated with duration on dialysis (b=0. 102) and serum P (b=3.077), and was negatively correlated with diabetes mellitus (b=-1.294). Conclusions Serum iPTH level affected the prognosis of MHD patients. This level was positively correlated with duration on dialysis and serum P, and negatively correlated with diabetes.
出处 《中国血液净化》 2013年第4期195-198,共4页 Chinese Journal of Blood Purification
关键词 慢性肾脏病 血液透析 全段甲状旁腺激素 Chronic kidney disease Hemodialysis Intact parathyroid hormone
  • 相关文献

参考文献14

  • 1张凌.慢性肾脏病钙磷代谢紊乱及骨病的处理[J].中国实用内科杂志,2010,30(2):113-115. 被引量:40
  • 2Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism,mortality,and morbidity in maintenance hemodialysis[J].JAm Soc Nephrol, 2004, 15:2208-2218.
  • 3Kansal S,Fried L.Bone disease in elderly individualswith CKDLJJ. Adv Chronic Kidney Dis,2010 Jul,17:e41-51.
  • 4Kovesdy CP, Ureche V, Lu 几,Kalantar-Zadeh K. Outcomepredictability of serum alkaline phosphatase in men withpre-dialysis CKD[J]. Nephrol Dial Transplant. 2010 Sep,25:3003-311.
  • 5李铎,宋韩明,李文歌,姚力,张国锐,陈少轩,张凌.难治性继发性甲状旁腺功能亢进的相关因素分析[J].肾脏病与透析肾移植杂志,2012,21(2):115-119. 被引量:38
  • 6Roussanne MC, Lieberherr M. Human parathyroid cell prolif-eration in response to calcium, NPS R- 467, calcitrioland phosphate [J]. Eur J Clin Invest, 2001, 31 : 610-616.
  • 7Dusso AS, Lu Y, Pablopoulos T, et al. A role of enhancedexpression of transforming growth factor alpha (TGF-alpha)in the mitogenic effect of high dietary phosphorus onparathyroid cell growth in uremia[J]. J Am Soc Nephrol,1999,10:617.
  • 8PMID:Tominaga Y , Kohara S, Namii Y,et al. Clonal analysis ofnodular parathyroid hyperplasia in renal hyperplasia inrenal hyperparathyroidism[J]. World J Surg, 1996, 20? 744-752.
  • 9Drechsler C, Grootendorst DC, Boeschoten EW, etal. Changesin parathyroid hormone, body mass index and the associationwith mortality in dialysis patients[J]. Nephrol DialTransplant. 2011 Apr, 26:1340-6.
  • 10Chertow GM, Plone M, Dillon MA, etal. Hyperparathyroidismand duration on dialysis [J]. Clin Nephrol, 2000,10, 54:295-300.

二级参考文献63

  • 1钱家麒.关注血液透析中若干问题,进一步提高血液透析治疗水平[J].中华肾脏病杂志,2005,21(2):63-64. 被引量:30
  • 2<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97
  • 3陈香美,王海燕.提高慢性肾脏病的知晓率、治疗率和控制率减轻对国民健康的危害[J].中华内科杂志,2006,45(6):441-442. 被引量:65
  • 4Moranne O, Froissart M, Rossert J, et al. Timing of onset of CKD- Related metabolic complications [J]. J Am Soc Nephrol, 2009 ;20 : 164 - 171.
  • 5Fraser WD. Hyperparathyroidism [ J ]. Lancet, 2009,347 : 145 - 157.
  • 6Goodman WG, Goldin J, Kuizon BD, et al. Coroary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis [ J ]. N Eng J Med ,2000 ,342 : 1478 - 1483.
  • 7Kidney Disease : Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guidelines the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[ J]. Kidney Int, 2009,76 (Suppl 113 ) : S1- S130.
  • 8Teresa A, Joao MF. Cardiovascular risk in dialysis patients:X-ray vision on vascular calfications [ J ]. Kidney Int, 2008,74 : 1505 - 1507.
  • 9Bryan K, Dennis LA, Stephen MS, et al. Suevival following parathyroidectomy among United States dialysis patients [ J ]. Kidney Int ,2004,65:2010.
  • 10徐元钊,林善琰.慢性肾功能衰竭[M].见:陈灏珠主编,实用内科学.第10版.北京:人民卫生出版社,1997:1755-1764.

共引文献183

同被引文献61

  • 1张志勇,李明旭,余永武,周春华.日间非卧床腹膜透析与持续非卧床腹膜透析长期临床疗效观察[J].中国血液净化,2012,11(3):131-135. 被引量:22
  • 2Puttinger H.Peritoneal dialysis--an ideal initial dialysis mode[J].Wien Med Wochenschr,2013,163(11/12):271-279.
  • 3Lin YF,Huang JW,Wu Ms,et al.Comparison of residual renal function in patient undergoing twice-weekly versus threetimes-weekly haemodialysis[J].Nephrology (Carton),2009,14(1):59-64.
  • 4Perl J,Bargman JM.The importance of residual kidney function for patients on dialysis:a critical review[J].Am J Kidney Dis,2009,53(6):1068-1081.
  • 5van der Wal WM,Noordzij M,Dekker FW,et al.Full loss of residual renal function causes higher mortality in dialysis patients:findings from a marginal structural model[J].Nephrol Dial Transplant,2011,26 (9):2978-2983.
  • 6Zhe XW,Tisn XK,Cheng L,et al.Effects of peritioneal resting on peritoneal on peritoneal fluid transport kinetics[J].Peritics Perit Disl Int,2007,27(5):575-579.
  • 7Tam P.Peritoneal dialysis and preservation of residual renal function[J].Perit Dial Int,2009,29(Suppl 2):S108-Sl10.
  • 8Levin A,Bakris GL,Molitch M,et al.Prevalence of abnormal serum vitamin D,PTH,calcium,and phosphorus in patients with chronic kidney disease:results of the study to evaluate early kidney disease[J].Kidney Int,2007,71(1):31-38.
  • 9Palmer SC,Hayen A,Macaskill P,et al.Serum levels of phosphorus,parathyroid hormone,and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease:a systematic review and meta-analysis[J].JAMA,2011,305(11):1119-1127.
  • 10Lee CT,Tsai YC,Ng HY,et al.Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients:a cross-sectional study[J].J Ren Nutr,2009,19(3):220-227.

引证文献8

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部